Hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 44, Issue 13, 1997, Pages 307-312

  Johnson, Rod C ^a,b  

^a Hepato Gastroenterology   (Greece)

^b NONE   (Greece)

Author keywords

Adjuvant therapy; Diagnosis; Etiology; Hepato cellular carcinoma; Prognosis; Therapy

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CISPLATIN; DECARBOXYPROTHROMBIN; DOXORUBICIN; HORMONE; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; IODINATED POPPYSEED OIL; MITOMYCIN C;

ARTICLE; ARTIFICIAL EMBOLISM; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HORMONAL THERAPY; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; ETHANOL; HUMANS; INJECTIONS, INTRAVENOUS; LIVER NEOPLASMS; PROGNOSIS;

EID: 0031045145     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ferrari G. Surgical Treatment and Prognostic Variables of Hepatocellular Carcinoma in 122 Cirrhotics. Hepato-Gastroenterol 1995; 42: 222-229.
2. Okusaka T, et al. The Prognosis Of Patients With Hepatocellular Carcinoma of Multicentric Origin. Hepato-Gastroenterology. 1996; 43: 919-925.
3. Tanaka A, et al. Extension of surgical indication for advanced hepatocellular carcinoma: Is it possible to prolong life span or improve quality of life?. Hepato-Gastroenterology. 1996; 43: 1172-1181.
4. Tanaka A, et al. Implications of Surgical Treatment for Advanced Hepatocellular Carcinoma with Tumor Thrombi in the Portal Vein. Hepato-Gastroenterology. 1996; 43: 637-643.
5. Ezaki T, et al. Small Hepatic Nodules Surrounding Hepatocellular Carcinoma. Hepato-Gastroenterology. 1996; 43: 1182-1184.
6. Yamasaki T, et al. Clinicopathological Features of Early Hepatocellular Carcinoma. Hepato-Gastroenterology. 1996; 43: 926-931.
7. Miyakawa H, Izumi N, Manzmo F, Sato C. Roles of Alcohol, Hepatitis Virus Infection, and Gender in the development of Hepatocellular carcinoma in patients with liver cirrhosis. Alcohol Clin Exp Res, 1996; 20 91 A-94A.
8. Noda K, Yoshihara H, Suzuki K, et al. Progression of Type C Chronic Hepatitis to Liver Cirrhosis and Hepatocellular carcinoma-its relationship to alcohol drinking and the age of transfusion. Alcohol Clin Exp Res 1996; 20 (1): 95A-100A.
9. de Pangher Manzini V, Calcucci F, Terpin MM, et al. Multiple Primary Malignant Tumors in Patients with Hepatocellular Carcinoma. A Review of 29 Patients. Tumori 1996; 82: 245-248.
10. Matsuda, Y. Relation between Markers for Viral Hepatitis and Clinical Features of Japanese Patients with Hepatocellular Carcinoma: Possible Role of Alcohol in Promoting Carcinogenesis. Hepato-Gastroenterol 1995; 42: 151-154.
11. Miyagawa S, Kawasaki S, Makuuchi M. Comparison of the Characteristics of Hepatocellular Carcinoma between Hepatitis B and C Viral Infection: Tumor Multicentricity in Cirrhotic Liver with Hepatitis C. Hepatology 1996; 24: 307-310.
12. Ichida T, Van Thiel D, Hassanein T. The Medical Management of Hepatocellular Carcinoma in Japn: A Review with Implcations for HCC seen in the West. Hepato-Gastroenterol 1996; 43:1575-1583.
13. Jaskiewicz K, Banach L, Izycka E. Hepatocellular Carcinoma in Young Patients: Histology, Cellular Differentiation, HBV Infection and Oncoprotein p53. Anticancer Res. 1995;15 (6B): 2723-2725.
14. London WT, Evans AA, McGlynn K, et al. Viral, Host and Environmental Risk Factors for Heptocellular carcinoma: A Prospective Study in Haimen City, China. Intervirology 1995; 38: 155-161.
15. Fujiyama S. Early Detection of Hepatocellular Carcinoma Associated with Cirrhosis by Combined Assay of Des-γ-Carboxy Prothrombin and α-fetoprotein: Aprospective Study. Hepato-Gastroenterol 1995; 42: 387-393.
16. Hamazaki K, et al. Serum Levels Of Circulating Intercellular Adhesion Molecule 1 In Hepatocellular Carcinoma. Hepato-Gastroenterology. 1996; 43: 229-234.
17. Shimada M, et al. Chemosensitivity in Primary Liver Cancers: Evaluation of the Correlation between Chemosensitivity and Clinicopathological Factors. Hepato-Gastroenterology. 1996; 43: 1159-1164.
18. Okuno K, et al. Interleukin 12 Augments the Liver-associated Immunity and Reduces Liver Metastases. Hepato-Gastroenterology. 1996; 43: 1196-1202.
19. Kountouras, J. Recombinant a2 Interferon (a-IFN) with Chemo-Hormonal Therapy in Patients with Hepatocellular Carcinoma (HCC). Hepato-Gastroenterol 1995; 42: 31-36.
20. Lygidakis NJ. Resection versus Resection Combined with Adjuvant Pre- and Post-Operative Chemotherapy- Immunotherapy for Metastatic Colorectal Liver Cancer A New Look at an Old Problem. Hepato-Gastroenterol 1995; 42: 155-161.
21. Yasuhara M, Une Y, Shimamura T, et al. Efficacy of intra-arterial chemotherapy using a Reservoir (IA) for Patients with Unresectable Hepatocellular carcinoma. Gan To Kagaku Ryoho 1996; 23: 455-458.
22. Lygidakis NJ, Tsiliakos S. Multidisciplinary Management of Hepatocellular Carcinoma. Hepato-Gastroenterol. 1996; 43: 1611-1619.
23. Harada T, et al. Multimodal Treatment of Stage IVa Hepatocellular Carcinoma. Hepato-Gastroenterology. 1996; 43: 1154-1158.
24. Ishii H, et al. Effect of Percutaneous Ethanol Injection for Postoperative Recurrence of Hepatocellular Carcinoma in Combination with Transcatheter Arterial Embolization. Hepato-Gastroenterology. 1996; 43: 644-650.
25. Ishii H, et al. Predictive Factors for Recurrence after Percutaneous Ethanol Injection for Solitary Hepatocellular Carcinoma. Hepato-Gastro-enterology. 1996; 43: 938-943.
26. Kotoh K. The Use of Percutaneous Ethanol Injection Therapy for Recurrence of Hepatocellular Carcinoma. Hepato-Gastroenterol 1995; 42: 197-200.
27. Hsieh MY, Chen SC, Lu SN, et al. Treatment of Hepatocellular Carcinoma Smaller than 5 cm by Transcatheter Arterial Chemoembolization. Kao Hsiung Ko Hsueh Tsa Chih 1996; 12: 274-278.
28. Shiina S, Imamura M, Obi S, et al. Percutaneous Ethanol Injection Therapy for Small Hepatocellular Carcinoma. Gan To Kagaku Ryoho 1996; 23: 835-839.
29. Civalleri D, Pellicci R, Decaro G, et al. Palliative Chemoembolization of Hepatocellular Carcinoma with Mitoxantrone, Lipiodol and Gelfoam: A Phase II Study. Anticancer Res. 1996; 16: 93 7-941.
30. Uchida H, Matsuo N, Sakaguchi H, et al. Chemoembolization Therapy in Small Hepatocellular Carcinoma. Gan To Kagaku Ryoho 1996; 23: 840-848.
31. Yokoi H, Kawarada Y. Current Status of Treatment for Small Hepatocellular Carcinoma. Gan To Kagaku Ryoho 1996; 23: 8855-861.
32. Lee CS, Sheu JC, Wang M, Hsu HC. Long-term Outcome after Surgery for Asymptomatic Small Hepatocellular Carcinoma. Br J Surg 1996; 83: 330-333.
33. Inoue K, Makuuchi M, Takayama T, et al. Surgical Treatment of Small Hepatocellular Carcinoma. Gan To Kagaku Ryoho 1996; 23: 8849-854.
34. Hu RH, Lee PH, Yu SC, et al. Surgical Resection for Recurrent Hepatocellular Carcinoma: Prognosis and Analysis of Risk Factors. Srgery 1996; 120: 23-29.
35. Launois B, Chauvin J, Machado ML, et al. Surgical Treatment of Hepatocarcinoma in cirrhosis. Ann Gastroenterol. Hepatol 1996; 32: 35-39.
36. Wu CC, Ho WL, Yeh DC, et al. Hepatic Resection of Hepatocellular Carcinoma in Cirrhotic Livers: Is it Justified in Impaired Liver Function? Surgery 1996; 120; 34-39.
37. Fan ST, Lai EC, Lo CM, et al. Hepatectomy with an Ultrasonic Dissector for Hepatocellular Carcinoma. Br J Surg 1996; 83: 117-120.
38. Shuichi O. Influence Of Alcohol Abuse On Recurrence After Curative Resection Of Plepatocellular Carcinoma. Hepato-Gastroenterol 1995; 42: 958-963.
39. Shuto T, et al. Indications for, and EfFectiveness of, Second Hepatic Resection for Recurrent Hepatocellular Carcinoma, Hepato-Gastroenterol. 1996; 43: 932-937.
40. Nagasue N, Kohno H, Hayashi T, et al. Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma. Br J Surg 1996; 83: 127-131.
41. Harada T, Matsuo K, Inoue T, et al. Is Preoperative Hepatic Arterial Chemoembolization Safe and Effective for Hepatocellular Carcinoma? Ann Surg 1996; 224:4-9.
42. Ciferri E. Repeated Hepatic Resections for Recurrent Metastasis of Colorectal cancer. Hepato-Gastroenterol 1995; 42: 383-386.
43. Nishizaki T, et al. Nutritional Support after Hepatic Resection: A Randomized Prospective Study. Hepato-Gastroenterology. 1996; 43: 608-613.